Vimta Labs is currently trading at Rs 95.70, up by 6.00 points or 6.69% from its previous closing of Rs. 89.70 on the BSE.
The scrip opened at Rs. 90.80 and has touched a high and low of Rs. 97.65 and Rs. 88.55 respectively. So far 265087 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 114.50 on 01-Dec-2015 and a 52 week low of Rs. 59.35 on 29-Feb-2016.
Last one week high and low of the scrip stood at Rs. 94.45 and Rs. 76.25 respectively. The current market cap of the company is Rs. 206.93 crore.
The promoters holding in the company stood at 37.41%, while Institutions and Non-Institutions held 0.10% and 62.50% respectively.
Vimta Labs has reported over two fold jump in its net profit at Rs 2.71 crore for the quarter ended June 30, 2016 as compared to Rs 1.26 crore for the same quarter in the previous year. The company’s total income has increased by 34.23% to Rs 37.83 crore for the quarter under review from Rs 28.18 crore for the corresponding quarter of the previous year.
Vimta Labs is India’s leading contract research and testing organization. It has an envious track record of serving several market leaders across the globe.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1526.00 |
Dr. Reddys Lab | 6245.05 |
Cipla | 1400.00 |
Zydus Lifesciences | 959.05 |
Lupin | 1636.85 |
View more.. |